Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Study ID
- NCT03831958
- Status
- Recruiting
Conditions
- Cushing Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 90 Years
- Healthy Volunteers
- Accepted
Study Details
Background: The pituitary gland produces hormones. A tumor in this gland can cause it to produce too much of the hormone cortisol. Too much cortisol in the body causes Cushing disease. This disease causes many problems. Some of these problems might persist after the disease is cured. Objective: To find out the long-term effects of exposure to high levels of cortisol during childhood and adolescence. Eligibility: People ages 10-42years who were diagnosed with Cushing disease before age 21 and are now cured and have normal or low cortisol levels People related to someone with Cushing disease Design: Participants will be screened with a medical history. Participants will complete an online survey. This will include questions about their or their child s physical and mental health. All participants will be seen at 5 -year intervals after cure of Cushing disease (5yr, 10yr, 15yr, 20yr (last visit)) Participants who have a relative with Cushing disease will have a medical history and blood tests or cheek swabs. Participants who have the disease will have: Physical exam Blood tests Cheek swab DXA scan: A machine will x-ray the participant s body to measure bone mineral content. For participants who are still growing, a hand x-ray Participants with the disease may also have: Hormone stimulation test: Participants will get a hormone or another substance that will be measured. Serial hormone sampling: Participants blood will be measured several times through a thin plastic tube in an arm vein. Urine tests: Participants urine may be collected over 24 hours. MRI: Participants may have a dye injected into a vein. They will lie on a table that slides into a machine. The machine will take pictures of the body. ...
Key Dates
- Start date
- Mar 4, 2019
- Status verified
- Apr 2026
- Primary completion
- Jan 3, 2040
- Completion
- Jan 3, 2040
Study Design
- Enrollment
- 600 participants (estimated)
Arms
- Arm: Family memberFamily member of survivor of pediatric Cushing disease
- Arm: Subjectssurvivor of pediatric Cushing disease
Primary Outcome Measure
Difference in body mass index z-score of subjects previously treated for Cushing disease compared to general population [ Time Frame: baseline, 5, 10, 15, 20 years ]
Central Contacts
- Deborah P Merke, M.D.(301) 496-0718
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 |
Find similar trials in Bethesda, MD
Related Studies
- An Investigation of Pituitary Tumors and Related Hypothalmic DisordersRecruiting · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Bethesda, Maryland
- A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's SyndromePHASE1/PHASE2 · Recruiting · Crinetics Pharmaceuticals Inc. · Bethesda, Maryland
- Collecting Information About Treatment Results for Patients With Cushing's SyndromeRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Multicenter Study of Seliciclib (R-roscovitine) for Cushing DiseasePHASE2 · Recruiting · Cedars-Sinai Medical Center · Los Angeles, California